<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Pharmacology Unit 2 by Ashlianne Bokor</title>
      <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu</link>
      <description>Made with a focused mind!</description>
      <language>en-us</language>
      <pubDate>2021-04-11 20:29:25 UTC</pubDate>
      <lastBuildDate>2026-01-24 21:10:45 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f9e0.png</url>
      </image>
      <item>
         <title>Division 1 of the Autonomic Nervous System</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404907445</link>
         <description><![CDATA[<div>Sympathetic Nervous System aka Adrenergic</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 20:34:42 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404907445</guid>
      </item>
      <item>
         <title>Division 2 of the Autonomic Nervous System</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404911685</link>
         <description><![CDATA[<div>Parasympathetic Nervous System aka Cholinergic</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 20:37:49 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404911685</guid>
      </item>
      <item>
         <title>SNS Neurotransmitters and their Release Locations</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404915869</link>
         <description><![CDATA[<ul><li>Acetylcholine (ACH): ganglia from presynaptic nerve endings</li><li>Norepinephrine (NE): postganglionic nerve endings, adrenal medulla</li><li>Epinephrine (EPI): adrenal medulla</li><li>Dopamine (DA): formed as a precursor in the synthesis of norepinephrine in peripheral adrenergic nerve endings</li></ul>]]></description>
         <pubDate>2021-04-11 20:41:15 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404915869</guid>
      </item>
      <item>
         <title>PNS Neurotransmitters and their Release Locations</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404923965</link>
         <description><![CDATA[<ul><li>Acetylcholine (ACH): ganglia, postganglionic nerve endings</li></ul><div><br></div>]]></description>
         <pubDate>2021-04-11 20:47:38 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1404923965</guid>
      </item>
      <item>
         <title>SNS Receptors and their Locations</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405003360</link>
         <description><![CDATA[<ul><li>Alpha-1: glands, smooth muscle, eyes, most arteries and veins</li><li>Alpha-2: adrenergic nerve ending</li><li>Beta-1: heart</li><li>Beta-2: bronchiolar smooth muscle, uterus, coronary and skeletal muscle arteries</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 21:50:52 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405003360</guid>
      </item>
      <item>
         <title>PNS Receptors and their Locations</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405004106</link>
         <description><![CDATA[<ul><li>Muscarinic: cardiac and smooth muscle, glands, parasympathetic postganglionic nerve endings&nbsp;</li><li>Nicotinic 1 (Nn): ganglia of parasympathetic nerves and sympathetic nerves (synapse area)&nbsp;</li><li>Nicotinic 2 (Nm): somatic, neuromuscular junction of skeletal muscle&nbsp;</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 21:51:35 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405004106</guid>
      </item>
      <item>
         <title>What happens when SNS neurotransmitters are stimulated?</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405013691</link>
         <description><![CDATA[<ul><li>Arteries: vasoconstriction (except coronary and skeletal muscle arteries, which are dilated)</li><li>Heart: increased heart rate and AV conduction</li><li>Intestines: GI motility and secretions decreased</li><li>Pupil of the eye: dilation (mydriasis)</li><li>Lower respiratory passages: bronchodilation</li><li>Urinary bladder: relaxation</li><li>Urinary sphincter: contraction</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 21:59:04 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405013691</guid>
      </item>
      <item>
         <title>What happens when PNS neurotransmitters are stimulated?</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405027147</link>
         <description><![CDATA[<ul><li>Heart: decreases heart rate and AV conduction, slight decrease in contractility</li><li>Intestines: GI motility and secretions increased</li><li>Pupil of the eye: constriction (miosis)</li><li>Lower respiratory passages: bronchoconstriction</li><li>Urinary bladder: contraction</li><li>Urinary sphincter: relaxation</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 22:09:00 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405027147</guid>
      </item>
      <item>
         <title>SNS Drug Classifications and their Drug Examples</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405042909</link>
         <description><![CDATA[<div>Alpha-1 Adrenergic Agonists<br>MOA:</div><ul><li>alpha-1 receptor is stimulated</li><li>contraction of smooth muscle, blood vessels constrict, increases blood pressure</li><li>vasoconstriction of nasal passages = decongestant effect</li></ul><div>Drugs:</div><ul><li>ephedrine</li><li>phenylephrine (Neo-Synephrine®)</li></ul><div>Adrenergic Agonists<br>MOA:</div><ul><li>Stimulates all alpha and beta receptors</li><li>Vasopressor-vasoconstriction, increases blood pressure</li><li>Cardiac stimulant</li><li>Bronchodilator</li></ul><div>Drugs:</div><ul><li>epinephrine (Adrenalin®)</li></ul><div>Alpha-1 Adrenergic Blocking Drugs<br>MOA:</div><ul><li>binds to alpha-1 receptors and blocks them</li><li>relaxation of smooth muscle</li><li>vasodilation of blood vessels, decreases blood pressure</li><li>relaxes smooth muscle of ureters and increases urine flow</li></ul><div>Drugs:</div><ul><li>prazosin (Minipress®)</li><li>terazosin (Hytrin®)</li><li>doxazosin (Cardura®)</li></ul><div>Beta-1 Adrenergic Agonists<br>MOA:</div><ul><li>Low dose: stimulates dopaminergic (d-1) receptors in kidneys causing vasodilation and increased renal blood flow</li><li>Moderate dose: stimulates beta-1 receptors causing heart to increase force of contraction and cardiac output</li><li>High dose: stimulates alpha-1 receptors causing vasoconstriction and increase in blood pressure</li></ul><div>Drugs:</div><ul><li>dobutamine</li></ul><div>Beta-2 Adrenergic Agonists<br>MOA:</div><ul><li>stimulates beta-2 receptors</li><li>relaxation of the smooth muscle of the lungs = bronchodilation</li><li>relaxation of the smooth muscle of the uterus</li></ul><div>Drugs:</div><ul><li>albuterol (Proventil®, Ventolin®)</li><li>terbutaline (Brethine®)</li><li>formoterol (Foradil®)</li><li>salmeterol (Serevent®)</li></ul><div>Selective Beta-1 Blockers<br>MOA:</div><ul><li>beta-1 receptor is blocked (antagonizes beta-1 effects of NE and EPI)</li><li>decreases force of contraction (negative inotropic), decreases cardiac output</li><li>decreases heart rate (negative chronotropic)</li><li>decreases conduction (negative dromotropic)</li><li>decrease in cardiac output also decreases blood pressure</li></ul><div>Drugs:</div><ul><li>atenolol (Tenormin®)</li><li>metoprolol (Lopressor®)</li></ul><div>Non-selective Beta Blockers<br>MOA:</div><ul><li>block beta-1 and beta-2 receptors</li><li>decreases force of contraction (negative inotropic), decreases cardiac output</li><li>decreases heart rate (negative chronotropic)</li><li>decreases conduction (negative dromotropic)</li><li>decrease in cardiac output also decreases blood pressure</li><li>can cause bronchoconstriction</li></ul><div>Drugs:</div><ul><li>nadolol (Corgard®)</li><li>propanolol (Inderal®)</li><li>timolol (Blocadren®)</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-11 22:21:41 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405042909</guid>
      </item>
      <item>
         <title>PNS Drug Classifications and their Drug Examples</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405043421</link>
         <description><![CDATA[<div>Direct–Acting Cholinergic Agonists&nbsp;<br>MOA:&nbsp;</div><ul><li>directly stimulates/binds to the muscarinic receptors in the parasympathetic division</li><li>mimics ACH</li><li>can more specifically lead to:<ul><li>pupil constriction</li><li>decrease in the amount of fluid in the eye</li><li>decrease in intraocular pressure</li><li>stimulation of muscarinic receptors of bladder and GI tract</li></ul></li></ul><div>Drugs:&nbsp;</div><ul><li>acetylcholine</li><li>pilocarpine (Pilocar®)</li><li>bethanechol (Urecholine®)</li></ul><div>Indirect–Acting Cholinergic Agonists&nbsp;<br>MOA:&nbsp;</div><ul><li>inhibits acetylcholinesterase, the enzyme that destroys ACH in the synapse&nbsp;</li><li>increases ACH&nbsp;</li></ul><div>Drugs:&nbsp;</div><ul><li>neostigmine (Prostigmin®)</li></ul><div>Anticholinergics<br>MOA:&nbsp;</div><ul><li>binds to a cholinergic receptor&nbsp;</li><li>acts as a blocking drug; competitive antagonism&nbsp;</li><li>can more specifically lead to:<ul><li>increase in heart rate</li><li>decrease in vagus nerve activity (parasympathetic)</li><li>decrease in GI secretions and motility</li><li>mydriasis</li><li>bronchodilation</li></ul></li></ul><div>Drugs:</div><ul><li>atropine</li><li>dicyclomine (Bentyl®)</li><li>ipratropium bromide (Atrovent®)</li></ul>]]></description>
         <pubDate>2021-04-11 22:22:17 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405043421</guid>
      </item>
      <item>
         <title>Sources</title>
         <author>ashliannedb</author>
         <link>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405311035</link>
         <description><![CDATA[<div>I used the course PowerPoints and textbook for all of my information.</div><ul><li>U2 ANS Part 1.pptx</li><li>U2 ANS Part 2.pptx</li><li>Pharmacology: An Introduction<ul><li>Henry Hitner, Ph.D.</li><li>Barbara Nagle, Ph.D.</li></ul></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2021-04-12 01:13:54 UTC</pubDate>
         <guid>https://padlet.com/ashliannedb/3gizs38mi6aja0iu/wish/1405311035</guid>
      </item>
   </channel>
</rss>
